XML 35 R15.htm IDEA: XBRL DOCUMENT v3.22.4
Leases
12 Months Ended
Dec. 31, 2022
Leases  
Leases

8. Leases

South San Francisco Lease and Subleases

As of December 31, 2022, the Company leased approximately 162,000 square feet of office and laboratory space in two buildings in South San Francisco, California, under a non-cancelable operating lease that ends in May 2030 (“SSF Lease”). The lease includes a tenant improvement allowance that expires in November 2024 and had a remaining balance of $8.9 million and $10.2 million, as of December 31, 2022 and 2021, respectively.

In June 2022, the Company entered into a non-cancelable agreement under which it subleased approximately 78,000 square feet of its South San Francisco office and laboratory space to an unaffiliated company. The sublease term continues through May 2030, consistent with the expiration of the SSF Lease, and the subtenant has no option to extend the sublease. Under the terms of the sublease, the Company is entitled to receive an initial monthly base rent of $0.5 million which will be subject to annual increases of 3%, as well as the subtenant’s proportionate share of the property’s operating expenses. As part the of the sublease terms, the subtenant was allocated $6.5 million of the Company’s $8.9 million remaining tenant improvement allowance. The Company expects to receive a total of $51.7 million in base rent over the sublease term which represents a $13.5 million premium (before sublease execution-related costs) over its proportionate lease payment obligations under the SSF Lease. Under the terms of the SSF Lease, 50% of the sublease premium, equal to approximately $6.7 million, shall be shared with the landlord and 50% shall be retained by the Company which equates to a base rent savings of approximately $0.8 million annually.

In July 2021, the Company entered into a non-cancelable agreement under which it subleased approximately 21,000 square feet of its South San Francisco office and laboratory space to another unaffiliated company. Under the terms of the sublease agreement, the sublease term continues through September 2028, and the parties have no option to extend the sublease. Either the Company or the subtenant may terminate the sublease by giving the other party ten days prior written notice. The Company is entitled to receive an initial monthly base rent of $0.1 million, with annual base rent increases of 3% and the subtenant’s proportionate share of the building’s operating expenses. The Company expects to receive a total of $13.1 million over the sublease term which represents a $4.2 million premium (before sublease execution-related costs) over its proportionate lease payment obligations under the SSF Lease. Under the terms of the head SSF Lease, 50% of the sublease premium, equal to $2.1 million, shall be shared with the landlord and 50% shall be retained by the Company.

The Company recognizes the sublease income on a straight-line basis over the term of its two subleases which is reflected as a reduction of R&D expense and selling, general and administrative expenses in the consolidated statements of operations. No lease modification was deemed to have occurred by entering into the sublease agreements because the Company was not released, either fully or in part, from its obligations under the SSF Lease.

Sublease income related to the sublease agreements, including base rent and certain sublease transaction cost reimbursements from the landlord, was $5.0 million and $0.5 million for the year ended December 31, 2022 and 2021, respectively.

Dublin Lease

In April 2017, the Company leased approximately 6,100 square feet of office space in Dublin, Ireland, under a non-cancelable operating lease that expires in April 2027 (“Dublin Lease”). In May 2022, the Company entered into an agreement under which it assigned the Dublin Lease (“Lease Assignment”) to an unaffiliated company. The Company determined that the Lease Assignment would be accounted for as a lease modification under ASC 842, Leases. As a result of the lease modification, the Company reduced the value of its operating lease assets and liabilities in the consolidated balance sheets by $1.4 million and $1.5 million, respectively, in the second quarter of 2022. Under the Lease Assignment, the Company sold furniture and equipment located in the Dublin office to the unaffiliated company and recognized a net loss of $0.1 million from the sale.

Following the execution of the Lease Assignment, in May 2022, the Company entered into a new operating lease agreement for approximately 700 square feet of office space in Dublin, Ireland, effective June 2022. The lease has a two-year term ending in May 2024, and the Company may terminate the lease by providing three months prior written notice. Under the new lease, the Company will incur total base rent expense of approximately $0.4 million (or $0.2 million annually) which is recognized on straight-line basis over the two-year lease term. The Company’s annual straight-line base rent for its previous Dublin Lease was approximately $0.4 million.

The Company has evaluated its existing leases and determined that they were all operating leases. The present values of the remaining lease payments and corresponding right-of-use assets were as follows, and the difference between the right-of-use assets and lease liabilities was primarily due to office-related deferred rent payments that are payable in future periods and tenant improvement reimbursements.

(In thousands)

Classification

    

December 31, 2022

    

December 31, 2021

Assets

Operating lease assets

Operating lease assets

$

40,126

$

39,690

Liabilities

Current:

Operating lease liabilities

Operating lease liabilities

$

6,753

$

503

Non-current:

Operating lease liabilities

Long-term operating lease liabilities

 

45,407

 

52,681

Total operating lease liabilities

$

52,160

$

53,184

Lease expense and sublease income were included within operating expenses in the consolidated statements of operations as follows:

Year Ended

Year Ended

Year Ended

(In thousands)

Classification

    

December 31, 2022

    

December 31, 2021

    

December 31, 2020

Operating lease expense

Selling, general and administrative expense

$

8,314

$

6,248

$

7,974

Operating lease expense

Research and development expense

1,377

758

Total operating lease expense (1)

$

8,314

$

7,625

$

8,732

Year Ended

Year Ended

Year Ended

(In thousands)

Classification

    

December 31, 2022

    

December 31, 2021

    

December 31, 2020

Operating sublease income

Selling, general and administrative expense

$

5,420

$

466

$

(1)Excludes short-term leases which were not material and office lease service-related charges.

Cash paid for amounts included in the measurement of lease liabilities was as follows:

Year Ended

Year Ended

(In thousands)

    

December 31, 2022

    

December 31, 2021

Cash paid for amounts included in the measurement of lease liabilities:

Operating cash flows from operating leases

$

9,312

$

8,971

As of December 31, 2022, the maturities of the Company’s lease liabilities were as follows:

(In thousands)

Year ending December 31:

    

2023

$

9,947

2024

10,623

2025

10,828

2026

11,145

2027

11,479

Thereafter

28,576

Total operating lease payments

$

82,598

Less: Estimated tenant improvement allowance

(8,912)

Less: Imputed interest

(21,526)

Present value of operating lease liabilities

$

52,160

As of December 31, 2022, the undiscounted cash flows to be received related to the Company’s subleases were as follows:

(In thousands)

Year ending December 31:

    

2023

$

7,713

2024

7,944

2025

8,181

2026

8,425

2027

8,675

Thereafter

18,502

Total operating sublease receipts

$

59,438

As of December 31, 2022, the weighted-average remaining lease term was 7.4 years, and the weighted-average discount rate used to determine the lease liabilities was 8.63%. The Company’s discount rate was primarily derived from the 9.0% interest rate on its previously issued Non-Recourse 2033 Notes in November 2018 and did not involve any significant assumptions.